4//SEC Filing
Marshall Randall 4
Accession 0001179110-20-009590
CIK 0001359931other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 4:39 PM ET
Size
6.7 KB
Accession
0001179110-20-009590
Insider Transaction Report
Form 4
Marshall Randall
10% Owner
Transactions
- Sale
Common Stock
2020-09-03$20.19/sh−52$1,050→ 601,723 total - Sale
Common Stock
2020-09-02$20.68/sh−207$4,281→ 601,775 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.21 to $20.80, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.02 to $20.20, inclusive.
Documents
Issuer
Protara Therapeutics, Inc.
CIK 0001359931
Entity typeother
Related Parties
1- filerCIK 0001799325
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 4:39 PM ET
- Size
- 6.7 KB